From the Department of Medicine, Division of Cardiology, Emory University
School of Medicine, Atlanta, Ga.
Correspondence to Kathy K. Griendling, PhD, Emory University School of Medicine, Division of Cardiology, 1639 Pierce Dr, 319 WMB, Atlanta, GA 30322. E-mail kgriend{at}emory.edu
AbstractCaveolae are membrane
domains that have been implicated in signal transduction, and caveolins
are major structural components of these domains. We found that all
reported caveolin isoforms (caveolin-1, -2, and -3) were expressed in
vascular smooth muscle cells (VSMCs); however, only caveolin-1 mRNA was
regulated by angiotensin II (Ang II). Ang II (100 nmol/L)
increased caveolin-1 mRNA, with a peak at 2 hours (193±6% of control,
P<0.01, n=4). In contrast, Ang II significantly
decreased caveolin-1 protein, with a nadir at 4 hours (64±5% of
control, P<0.01, n=6). [35S]Methionine
labeling showed that Ang II increased caveolin biosynthesis (226±33%
of control labeling at 4 hours), suggesting that the transient decrease
in caveolin protein levels is due to increased degradation. When cells
were fractionated with sucrose, on agonist stimulation, AT1
receptors appeared in fraction 5 where caveolin was fractionated. This
migration was blocked by low temperature and treatment with
phenylarsine oxide, interventions that interfere with agonist-induced
Ang II type 1 (AT1) receptor sequestration and tonic phase
signaling. In addition, caveolin-1 coimmunoprecipitates with
AT1 receptor only on agonist stimulation. These data
support the concept that the caveola is a specialized signaling domain
in VSMCs that can be dynamically accessed by the AT1
receptor. Because of the signaling and coupling proteins that are
localized in caveolae and because of evidence that these proteins may
interact directly with caveolin, caveolaAT1 receptor
interaction likely represents an important focus for dynamic
control of receptor signaling in VSMCs.
© 1998 American Heart Association, Inc.
Scientific Contributions
Angiotensin II Type 1 Receptor
Relationship With Caveolae and Caveolin After Initial Agonist Stimulation
Key Words: angiotensin II signal transduction receptors, angiotensin
This article has been cited by other articles:
![]() |
X. C. Li, U. Hopfer, and J. L. Zhuo AT1 receptor-mediated uptake of angiotensin II and NHE-3 expression in proximal tubule cells through a microtubule-dependent endocytic pathway Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1342 - F1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Heakal and M. Kester Nanoliposomal Short-Chain Ceramide Inhibits Agonist-Dependent Translocation of Neurotensin Receptor 1 to Structured Membrane Microdomains in Breast Cancer Cells Mol. Cancer Res., May 1, 2009; 7(5): 724 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, R. H. Henning, M. Sandovici, J. J. van der Want, W. H. van Gilst, and H. Buikema Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae numbers and altered AT1- and epidermal growth factor-receptor function Eur J Heart Fail, March 1, 2009; 11(3): 246 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Peterson, L. V. d'Uscio, S. Cao, X.-L. Wang, and Z. S. Katusic Guanosine Triphosphate Cyclohydrolase I Expression and Enzymatic Activity Are Present in Caveolae of Endothelial Cells Hypertension, February 1, 2009; 53(2): 189 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yin, B. Li, H. Chen, and K. J. Catt Differential Signaling Pathways in Angiotensin II- and Epidermal Growth Factor-stimulated Hepatic C9 Cells Mol. Pharmacol., November 1, 2008; 74(5): 1223 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Yang, M. B. Sandberg, A. D. Can, K. Pihakaski-Maunsbach, and A. A. McDonough Effects of dietary salt on renal Na+ transporter subcellular distribution, abundance, and phosphorylation status Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1003 - F1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Pojoga, T. M. Yao, S. Sinha, R. L. Ross, J. C. Lin, J. D. Raffetto, G. K. Adler, G. H. Williams, and R. A. Khalil Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1258 - H1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mogi, M. Iwai, and M. Horiuchi Emerging Concepts of Regulation of Angiotensin II Receptors: New Players and Targets for Traditional Receptors Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2532 - 2539. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mendez-Bolaina, J. Sanchez-Gonzalez, I. Ramirez-Sanchez, E. Ocharan-Hernandez, M. Nunez-Sanchez, E. Meaney-Mendiolea, A. Meaney, J. Asbun-Bojalil, A. Miliar-Garcia, I. Olivares-Corichi, et al. Effect of caveolin-1 scaffolding peptide and 17 -estradiol on intracellular Ca2+ kinetics evoked by angiotensin II in human vascular smooth muscle cells Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1953 - C1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Linder, K. M. Thakali, J. M. Thompson, S. W. Watts, R. C. Webb, and R. Leite Methyl-beta-cyclodextrin Prevents Angiotensin II-Induced Tachyphylactic Contractile Responses in Rat Aorta J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 78 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
Jie Zhang, A. Kendrick, S. Quenby, and S. Wray Contractility and Calcium Signaling of Human Myometrium Are Profoundly Affected by Cholesterol Manipulation: Implications for Labor? Reproductive Sciences, July 1, 2007; 14(5): 456 - 466. [Abstract] [PDF] |
||||
![]() |
P. K. Mehta and K. K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol, January 1, 2007; 292(1): C82 - C97. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ushio-Fukai and R. W. Alexander Caveolin-Dependent Angiotensin II Type 1 Receptor Signaling in Vascular Smooth Muscle Hypertension, November 1, 2006; 48(5): 797 - 803. [Full Text] [PDF] |
||||
![]() |
M. Ushio-Fukai Localizing NADPH Oxidase-Derived ROS Sci. Signal., August 22, 2006; 2006(349): re8 - re8. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Savi, J.-L. Zachayus, N. Delesque-Touchard, C. Labouret, C. Herve, M.-F. Uzabiaga, J.-M. Pereillo, J.-M. Culouscou, F. Bono, P. Ferrara, et al. The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts PNAS, July 18, 2006; 103(29): 11069 - 11074. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Hassan, T. M. Williams, P. G. Frank, and M. P. Lisanti Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2393 - H2401. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hunyady and K. J. Catt Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II Mol. Endocrinol., May 1, 2006; 20(5): 953 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Orlichenko, B. Huang, E. Krueger, and M. A. McNiven Epithelial Growth Factor-induced Phosphorylation of Caveolin 1 at Tyrosine 14 Stimulates Caveolae Formation in Epithelial Cells J. Biol. Chem., February 24, 2006; 281(8): 4570 - 4579. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Louden, D. Brott, A. Katein, T. Kelly, S. Gould, H. Jones, G. Betton, J.-P. Valetin, and R. J. Richardson Biomarkers and Mechanisms of Drug-Induced Vascular Injury in Non-Rodents Toxicol Pathol, January 1, 2006; 34(1): 19 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ushio-Fukai, L. Zuo, S. Ikeda, T. Tojo, N. A. Patrushev, and R. W. Alexander cAbl Tyrosine Kinase Mediates Reactive Oxygen Species- and Caveolin-Dependent AT1 Receptor Signaling in Vascular Smooth Muscle: Role in Vascular Hypertrophy Circ. Res., October 14, 2005; 97(8): 829 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A Voors, P. P. van Geel, H. Buikema, M. Oosterga, D. J van Veldhuisen, and W. H van Gilst High Angiotensin II Responsiveness is Associated with Decreased Endothelium-Dependent Relaxation in Human Arteries Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 145 - 150. [Abstract] [PDF] |
||||
![]() |
L. Zuo, M. Ushio-Fukai, S. Ikeda, L. Hilenski, N. Patrushev, and R. W. Alexander Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscle Cells: Role in Redox Signaling and Vascular Hypertrophy Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1824 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Olivares-Reyes, B. H. Shah, J. Hernandez-Aranda, A. Garcia-Caballero, M. P. Farshori, J. A. Garcia-Sainz, and K. J. Catt Agonist-Induced Interactions between Angiotensin AT1 and Epidermal Growth Factor Receptors Mol. Pharmacol., August 1, 2005; 68(2): 356 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Linder, L. P. McCluskey, K. R. Cole III, K. M. Lanning, and R. C. Webb Dynamic Association of Nitric Oxide Downstream Signaling Molecules with Endothelial Caveolin-1 in Rat Aorta J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 9 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Smith, E. B. Babiychuk, K. Noble, A. Draeger, and S. Wray Increased cholesterol decreases uterine activity: functional effects of cholesterol alteration in pregnant rat myometrium Am J Physiol Cell Physiol, May 1, 2005; 288(5): C982 - C988. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Sampson, Y. Hayabuchi, N. B. Standen, and C. Dart Caveolae Localize Protein Kinase A Signaling to Arterial ATP-Sensitive Potassium Channels Circ. Res., November 12, 2004; 95(10): 1012 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, J. Abramowitz, A. Askari, and J. C. Allen Role of caveolae in ouabain-induced proliferation of cultured vascular smooth muscle cells of the synthetic phenotype Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2173 - H2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zuo, M. Ushio-Fukai, L. L. Hilenski, and R. W. Alexander Microtubules Regulate Angiotensin II Type 1 Receptor and Rac1 Localization in Caveolae/Lipid Rafts: Role in Redox Signaling Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1223 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Han, K. J. Austin, P. W. Nathanielsz, S. P. Ford, M. J. Nijland, and T. R. Hansen Maternal nutrient restriction alters gene expression in the ovine fetal heart J. Physiol., July 1, 2004; 558(1): 111 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. SPAT and L. HUNYADY Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways Physiol Rev, April 1, 2004; 84(2): 489 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Attia, O. Feron, R. Goldschmeding, L. H. Radermakers, N. D. Vaziri, P. Boer, J.-L. Balligand, H. A. Koomans, and J. A. Joles Hypercholesterolemia in Rats Induces Podocyte Stress and Decreases Renal Cortical Nitric Oxide Synthesis via an Angiotensin II Type 1 Receptor-Sensitive Mechanism J. Am. Soc. Nephrol., April 1, 2004; 15(4): 949 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Hilenski, R. E. Clempus, M. T. Quinn, J. D. Lambeth, and K. K. Griendling Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 677 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bouley, T.-X. Sun, M. Chenard, M. McLaughlin, M. McKee, H. Y. Lin, D. Brown, and D. A. Ausiello Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells Am J Physiol Cell Physiol, October 1, 2003; 285(4): C750 - C762. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Peterson, M. E. Guicciardi, R. Gulati, L. S. Kleppe, C. S. Mueske, M. Mookadam, G. Sowa, G. J. Gores, W. C. Sessa, and R. D. Simari Caveolin-1 Can Regulate Vascular Smooth Muscle Cell Fate by Switching Platelet-Derived Growth Factor Signaling From a Proliferative to an Apoptotic Pathway Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1521 - 1527. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zeidan, J. Broman, P. Hellstrand, and K. Sward Cholesterol Dependence of Vascular ERK1/2 Activation and Growth in Response to Stretch: Role of Endothelin-1 Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1528 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Imbrogno, M. C. Cerra, and B. Tota Angiotensin II-induced inotropism requires an endocardial endothelium-nitric oxide mechanism in the in-vitro heart of Anguilla anguilla J. Exp. Biol., August 1, 2003; 206(15): 2675 - 2684. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Wyse, I. A. Prior, H. Qian, I. C. Morrow, S. Nixon, C. Muncke, T. V. Kurzchalia, W. G. Thomas, R. G. Parton, and J. F. Hancock Caveolin Interacts with the Angiotensin II Type 1 Receptor during Exocytic Transport but Not at the Plasma Membrane J. Biol. Chem., June 20, 2003; 278(26): 23738 - 23746. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Marie, I. Lecoq, P. Jauzac, and S. Allouche Differential Sorting of Human {delta}-Opioid Receptors after Internalization by Peptide and Alkaloid Agonists J. Biol. Chem., June 13, 2003; 278(25): 22795 - 22804. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Pike Lipid rafts: bringing order to chaos J. Lipid Res., April 1, 2003; 44(4): 655 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schling and T. Schafer Human Adipose Tissue Cells Keep Tight Control on the Angiotensin II Levels in Their Vicinity J. Biol. Chem., December 6, 2002; 277(50): 48066 - 48075. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Leclerc, M. Auger-Messier, P. M. Lanctot, E. Escher, R. Leduc, and G. Guillemette A Polyaromatic Caveolin-Binding-Like Motif in the Cytoplasmic Tail of the Type 1 Receptor for Angiotensin II Plays an Important Role in Receptor Trafficking and Signaling Endocrinology, December 1, 2002; 143(12): 4702 - 4710. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Ostrom, X. Liu, B. P. Head, C. Gregorian, T. M. Seasholtz, and P. A. Insel Localization of Adenylyl Cyclase Isoforms and G Protein-Coupled Receptors in Vascular Smooth Muscle Cells: Expression in Caveolin-Rich and Noncaveolin Domains Mol. Pharmacol., November 1, 2002; 62(5): 983 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dreja, M. Voldstedlund, J. Vinten, J. Tranum-Jensen, P. Hellstrand, and K. Sward Cholesterol Depletion Disrupts Caveolae and Differentially Impairs Agonist-Induced Arterial Contraction Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1267 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shu, L. Lee, and J. A. Shayman Regulation of Phospholipase C-gamma Activity by Glycosphingolipids J. Biol. Chem., May 17, 2002; 277(21): 18447 - 18453. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Yarbrough, T. Lu, H.-C. Lee, and E. F. Shibata Localization of Cardiac Sodium Channels in Caveolin-Rich Membrane Domains: Regulation of Sodium Current Amplitude Circ. Res., March 8, 2002; 90(4): 443 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Shah, J. Alberto Olivares-Reyes, A. Yesilkaya, and K. J. Catt Independence of Angiotensin II-Induced MAP Kinase Activation from Angiotensin Type 1 Receptor Internalization in Clone 9 Hepatocytes Mol. Endocrinol., March 1, 2002; 16(3): 610 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ushio-Fukai, L. Hilenski, N. Santanam, P. L. Becker, Y. Ma, K. K. Griendling, and R. W. Alexander Cholesterol Depletion Inhibits Epidermal Growth Factor Receptor Transactivation by Angiotensin II in Vascular Smooth Muscle Cells. ROLE OF CHOLESTEROL-RICH MICRODOMAINS AND FOCAL ADHESIONS IN ANGIOTENSIN II SIGNALING J. Biol. Chem., December 14, 2001; 276(51): 48269 - 48275. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Modrall, M. Nanamori, J. Sadoshima, D. C. Barnhart, J. C. Stanley, and R. R. Neubig ANG II type 1 receptor downregulation does not require receptor endocytosis or G protein coupling Am J Physiol Cell Physiol, September 1, 2001; 281(3): C801 - C809. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Muller, C. Jung, S. Wied, S. Welte, H. Jordan, and W. Frick Redistribution of Glycolipid Raft Domain Components Induces Insulin-Mimetic Signaling in Rat Adipocytes Mol. Cell. Biol., July 15, 2001; 21(14): 4553 - 4567. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Gáborik, M. Szaszák, L. Szidonya, B. Balla, S. Paku, K. J. Catt, A. J. L. Clark, and L. Hunyady {beta}-Arrestin- and Dynamin-Dependent Endocytosis of the AT1 Angiotensin Receptor Mol. Pharmacol., February 1, 2001; 59(2): 239 - 247. [Abstract] [Full Text] |
||||
![]() |
R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Darby, C. Y. Kwan, and E. E. Daniel Caveolae from canine airway smooth muscle contain the necessary components for a role in Ca2+ handling Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1226 - L1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tang, T. Nishishita, T. Fitzgerald, E. J. Landon, and T. Inagami Inhibition of AT1 Receptor Internalization by Concanavalin A Blocks Angiotensin II-induced ERK Activation in Vascular Smooth Muscle Cells. INVOLVEMENT OF EPIDERMAL GROWTH FACTOR RECEPTOR PROTEOLYSIS BUT NOT AT1 RECEPTOR INTERNALIZATION J. Biol. Chem., April 28, 2000; 275(18): 13420 - 13426. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Okamoto, H. Ninomiya, S. Miwa, and T. Masaki Cholesterol Oxidation Switches the Internalization Pathway of Endothelin Receptor Type A from Caveolae to Clathrin-coated Pits in Chinese Hamster Ovary Cells J. Biol. Chem., February 25, 2000; 275(9): 6439 - 6446. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Lasley, P. Narayan, A. Uittenbogaard, and E. J. Smart Activated Cardiac Adenosine A1 Receptors Translocate Out of Caveolae J. Biol. Chem., February 11, 2000; 275(6): 4417 - 4421. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Carman, M. P. Lisanti, and J. L. Benovic Regulation of G Protein-coupled Receptor Kinases by Caveolin J. Biol. Chem., March 26, 1999; 274(13): 8858 - 8864. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Werbonat, N. Kleutges, K. H. Jakobs, and C. J. van Koppen Essential Role of Dynamin in Internalization of M2 Muscarinic Acetylcholine and Angiotensin AT1A Receptors J. Biol. Chem., July 14, 2000; 275(29): 21969 - 21974. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Igarashi and T. Michel Agonist-modulated Targeting of the EDG-1 Receptor to Plasmalemmal Caveolae. eNOS ACTIVATION BY SPHINGOSINE 1-PHOSPHATE AND THE ROLE OF CAVEOLIN-1 IN SPHINGOLIPID SIGNAL TRANSDUCTION J. Biol. Chem., October 6, 2000; 275(41): 32363 - 32370. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Yarbrough, T. Lu, H.-C. Lee, and E. F. Shibata Localization of Cardiac Sodium Channels in Caveolin-Rich Membrane Domains: Regulation of Sodium Current Amplitude Circ. Res., March 8, 2002; 90(4): 443 - 449. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |